Tscan Therapeutics Inc (TCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -26,127 | -13,658 | N/A | N/A |
| Depreciation Amortization | 1,230 | 519 | N/A | N/A |
| Accounts payable and accrued liabilities | 1,127 | 161 | N/A | N/A |
| Other Working Capital | 21,357 | 299 | N/A | N/A |
| Other Operating Activity | -610 | 157 | 0 | 0 |
| Operating Cash Flow | $-3,023 | $-12,522 | $N/A | $N/A |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -4,238 | -1,247 | N/A | N/A |
| Investing Cash Flow | $-4,238 | $-1,247 | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | 288 | 5 | N/A | N/A |
| Other Financing Activity | 0 | 34,807 | 0 | 0 |
| Financing Cash Flow | $288 | $34,812 | $N/A | $N/A |
| Beginning Cash Position | 42,359 | 21,316 | N/A | N/A |
| End Cash Position | 35,386 | 42,359 | N/A | N/A |
| Net Cash Flow | $-6,973 | $21,043 | $N/A | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -3,023 | -12,522 | N/A | N/A |
| Capital Expenditure | -4,238 | -1,247 | N/A | N/A |
| Free Cash Flow | -7,261 | -13,769 | 0 | 0 |